hero image

Biogen Idec to Present at the Bank of America Merrill Lynch 2011 Healthcare Conference

May 4, 2011 News Release

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Bank of America Merrill Lynch 2011 Healthcare Conference will be webcast live on Tuesday, May 10, 2011 at 1:00 p.m. PDT. To access the live webcast, please visit Biogen Idec’s Investor Relations section (investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Biogen Idec uses cutting edge science to discover, develop, manufacture and market therapeutic products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies and the company generates more than $4 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.

Contact:

 

Biogen Idec
Karen Jewell, 781-464-2442
Investor Relations

thumb
November 16, 2023
Biogen to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Cambridge, MA, - - Biogen.com announced today that Priya Sighal, M.D., M.P.H., Head of Development, will participate in the 6th Annual Evercore ISI HealthCONx Conference. The webcast will be live on Tuesday, Nov 28, 2023, at 9:10 a.m. ET. To access the live webcast, please visit the Investors

thumb
November 8, 2023
Biogen Reports Third Quarter 2023 Results